Mettler-Toledo International (NYSE:MTD) Price Target Increased to $1,450.00 by Analysts at Evercore ISI

Mettler-Toledo International (NYSE:MTDGet Free Report) had its price objective raised by stock analysts at Evercore ISI from $1,375.00 to $1,450.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has an “in-line” rating on the medical instruments supplier’s stock. Evercore ISI’s price target points to a potential downside of 2.03% from the stock’s previous close.

Several other equities analysts have also commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Jefferies Financial Group reissued an “underperform” rating and issued a $1,250.00 price target (up from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. The Goldman Sachs Group upped their price target on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a report on Tuesday, July 9th. Finally, Wells Fargo & Company started coverage on shares of Mettler-Toledo International in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $1,363.75.

Read Our Latest Stock Analysis on Mettler-Toledo International

Mettler-Toledo International Stock Down 1.3 %

MTD stock traded down $19.64 during trading on Tuesday, hitting $1,480.06. 61,039 shares of the company’s stock traded hands, compared to its average volume of 134,239. Mettler-Toledo International has a 52 week low of $928.49 and a 52 week high of $1,546.93. The stock has a fifty day moving average price of $1,419.52 and a two-hundred day moving average price of $1,382.39. The stock has a market capitalization of $31.61 billion, a price-to-earnings ratio of 41.51, a price-to-earnings-growth ratio of 3.75 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping the consensus estimate of $9.00 by $0.65. The business had revenue of $946.75 million during the quarter, compared to analyst estimates of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The company’s quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $10.19 earnings per share. As a group, equities research analysts expect that Mettler-Toledo International will post 40.35 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at $1,044,459.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $6,884,514. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its holdings in Mettler-Toledo International by 8.0% in the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock worth $117,000 after buying an additional 7 shares during the last quarter. UMB Bank n.a. increased its holdings in Mettler-Toledo International by 6.6% in the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 7 shares during the last quarter. Gulf International Bank UK Ltd increased its holdings in Mettler-Toledo International by 0.4% in the first quarter. Gulf International Bank UK Ltd now owns 1,813 shares of the medical instruments supplier’s stock worth $2,413,000 after buying an additional 8 shares during the last quarter. Bellevue Group AG increased its holdings in Mettler-Toledo International by 32.0% in the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock worth $44,000 after buying an additional 8 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Mettler-Toledo International by 7.2% in the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after buying an additional 8 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.